The WHO recommends that healthcare systems worldwide implement single-dose vaccine programs to help eliminate cervical cancer. On December 20, 2022, the World Health Organization (WHO) updated its recommendations for...
The 4-7 April convening of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been emerging over past years that single-dose schedules provide comparable efficacy to the...
One dose of human papillomavirus (HPV) vaccine has comparable effectiveness to two or three doses for preventing cervical pre-cancer, according to a new study. In a large national data linkage study published in...
A recent review of the human papillomavirus (HPV) vaccine is has found that in the 10 years since its original release, the infection rate of HPV has been lowered by up to 90 percent in countries with high levels of...
While the protective benefits of the HPV vaccine in the general population are well known, new research shows it may also benefit children with weakened immune systems who are at higher risk of HPV-related cancers. The...
A vaccine introduced a decade ago to combat the sexually transmitted virus that causes cervical cancer has already reduced the virus’s prevalence in teenage girls by almost two-thirds, federal researchers said. Even for...
Changes to vaccination protocols against meningococcal serotype B (MenB) and human papillomavirus (HPV) are some of the most significant in the 2016 immunization schedule released recently by the Advisory Committee on...
New research suggests that a recently developed human papillomavirus (HPV) vaccine can potentially prevent 80 percent of cervical cancers if it is administered before the child is 11 or 12 years old. HPV is a common...
University of Alabama at Birmingham (UAB) Division of Gynecologic Oncology director Warner Huh, M.D. says a new human papillomavirus (HPV) vaccine has the potential to reduce cervical cancer rates, while reducing the...